Mucopolysaccharidosis I (MPS I) is a rare, recessively inherited,
lysosomal storage disorder caused by deficiency on the
enzyme α-L-iduronidase. This defect results in accumulation
of heparan and dermatan sulfate in different tissues and organs
due to a deficiency in the catabolism of glycosaminoglycans.
The overall incidence of MPS I is 0.99-1.99/100.000 live
births. There are three clinical presentations: Hurler (severe),
Hurler Scheie (mild) and Scheie (mild). We report the case of
a 10-years-old male patient diagnosed with Hurler syndrome,
the severe presentation, 5 years ago by enzyme α-L-iduronidase
activity measurement in leukocytes; with a history of recurrent
respiratory infections, umbilical hernia, corneal opacity,
coarse facial features, macroglossia, hearing loss, stiffness of
joints, cardiac compromise, claw hands, mental retardation
and stunted growth. After enzyme replacement therapy the
patient has shown improvement of visceral symptoms, but the
neurological damage continuous in progress.
Key words: mucopolysaccharidosis, Hurler syndrome, MPS 1, Hurler,
genetic disorder, enzymatic replacement therapy, ERT
Authors: Amorín, Milagros; Carlina, Andrea; Prötzel, Ana
Source: Sociedad Argentina de Pediatría (SAP)
URL: http://hdl.handle.net/10757/313689
No hay comentarios:
Publicar un comentario